Topic: regulatory legislation

  • Unapproved Weight Loss Drugs: The Wellness Wild West Returns

    Unapproved Weight Loss Drugs: The Wellness Wild West Returns

    Influencers are heavily promoting the unapproved experimental drug retatrutide as "GLP-3," creating a dangerous gray market for weight loss seekers despite its lack of FDA approval and established safety profile. Retatrutide is a triple-hormone agonist currently in clinical trials, and its online...

    Read More »
  • UK Firms Fear Cyberattacks, Fines, and Reputational Fallout

    UK Firms Fear Cyberattacks, Fines, and Reputational Fallout

    UK business leaders rank cybersecurity breaches as their top risk, with 58% citing it as their foremost threat, yet 75% doubt their organization's preparedness, a concern grounded in recent experience. Following cyber threats, compliance issues and financial crime are major concerns, driven by ag...

    Read More »